Provision of Anti-Cancer Medicines in ECHS – Advisory: Order dated 23.01.2026
Tele:256E3476
Central Organisation ECHS
Integrated HQ of MoD (Army)
Adjutant General’s Branch
Thimayya Marg
Near Gopinath Circle
Delhi Cantt-1 10010
B/49762/AG/ECHS dated 23 Jan 2026
AMA ECHS, Embassy of India, Nepal
All Regional Centres
ADVISORY: PROVISION OF ANTI-CANCER MEDICINES IN ECHS
1 . Please refer the following:-
1.1. Govt of India, Ministry of Defence, DoESW letter No 22(16)/2025-D(WE)/Res-I dated 05 Dec 2025 (copy attached).
1.2. Office Memorandum of Govt of India, Ministry of Health & Family Welfare F.No. 5- 34/CGHS/HEC UA)12O25 dated 22 Dec 2025.
1.3. CO ECHS letter No B/49769/AG/ECHS dated 15 Jan 2026 (copy attached).
2. As per Para 3 of Annexure-II of letter ref mentioned at Para 1.1 above, ECHS will provide anti-cancer medicines whenever feasible. Accordingly, the parent ECHS Polyclinic will project the demand of prescribed anti-cancer medicines alongwith beneficiary details to the respective SEMO. In the event of non supply by ECHS, the empanelled HCO shall procure and administer the required medicines- In such instances HCO should either upload the purchase GST in forice (from external vendor) or shall submit the carton/outer pouch/vial reflecting batch no, manufacturing date, expiry date and MRP. Cost of such medicines shall be limited to 70% of MRP.
3. Anti-Cancer ECDL medicines for OPD Patients OIC Polyclinic will confirm stock availability from Polyclinic pharmacy and SEIVO (if kept with SEMO) on telephone/email. If not available, NAC (Printed on prescription) will be issued by ECHS Polyclinic, against which, the beneficiary may procure the medicines from local pharmacy and claim reimbursement as per extant policy.
4. Anti-Cancer Non EGDL medicines for OPD Patients The respective SEMO will issue the NAC (if not available in stock) against the dernand projected by ECHS Polyclinic with beneficiary details. Sanction for reimbursement will be issued by, N{D CO ECHS as per extant policy.
5. Anti-Cancer ECDL Medicines for IPD/Day Care Patients If prescribed anti-Cancer medicine is part of ECDL, OIC Polyclinic will confirm stock availability from Polyclinic pharmacy and SEMO on telephone/email, if not available, a ‘Referral cum NA’ will be issued by the ECHS Polyclinic with suitable remarks for “Anti-Cancer Drugs” as shown in sample referral form. The same will be submitted to the Emp HCO for continuation of treatment (Sample referral cum NA form attached).
6. Anti-Cancer Non ECDL Medicines for IPD/Day Care Patients OIC ECHS Polyclinic will confirm the availability of prescribed anit-cancer medicine from SEMO on telephone/email. After confirmation of non availability from SEMO, O/C ECHS Polyclinic will issue referral cum NA with suilable remarks for submission to Emp HCO for continuation of treatment
6. OsIC Polyclinic will maintain record of email communication with respective SEMOs for which they have issued NAC/Referral from NA. Further, to ensure continuity of cancer care and optimal utilization of resources, OIC ECHS Polyclinics shall maintain an updated record of all patients under going cancer treatment, including complete details of prescribed anticancer medicines. Based on this data anticipated monthly medicine requirements shall be projected to the concerned SEMOs to ensure timely availability. Any change in patient numbers or treatment protocols shall be promptly communicated to the respective SEMOs for effective planning and resource optimization
9. The contents of this advisory may pl be disseminated to all concerned under your AoR for necessary compliance.
10. This has approval of MD, ECHS
(Vikas Yadav)
Lt Col
Jt Dir (Med & Eqpt)
for MD ECHS
COMMENTS